Sign In
Buy IHE
$101.62
-0.84 (-0.82%)
At Close: Jul 31, 2026
XLV vs. IHE: Which Healthcare ETF Is the Better Buy?
11:53am, Friday, 31'st Jul 2026
The Health Care Select Sector SPDR Fund (XLV) carries a significantly lower expense ratio than the iShares U.S. Pharmaceuticals ETF (IHE). IHE concentrates exclusively on the pharmaceutical industry,
Will Generic Drug Tariffs Impact Pharma ETFs?
09:56am, Thursday, 30'th Jul 2026
New U.S. tariffs on generic drugs could pressure drugmakers and influence pharmaceutical ETFs. Here's what investors should watch.
Nikkei 225, Kospi jolt Asian markets as AI rout and Fed fears collide
12:28am, Thursday, 30'th Jul 2026
Asian stocks were mixed on Thursday as investors assessed the fallout from the AI sell-off, the Federal Reserve's rate outlook and renewed tensions in the Middle East. The MSCI Asia-Pacific gauge excl
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?
04:33pm, Wednesday, 22'nd Jul 2026
Vanguard Health Care ETF offers a significantly lower expense ratio of 0.09% compared to 0.38% for iShares U.S. Pharmaceuticals ETF iShares U.S. Pharmaceuticals ETF has delivered higher total returns
Kospi jumps 6% as Asia's battered semiconductor trade rebounds
12:32am, Wednesday, 22'nd Jul 2026
Asian stocks rallied on Wednesday as investors returned to semiconductor shares after a bruising sell-off, taking their cue from a Wall Street rebound even as Brent crude pushed further above $91 a ba
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?
06:27am, Sunday, 19'th Jul 2026
IHE pays a meaningfully higher dividend yield than BBH. BBH offers more concentrated exposure with 25 holdings, compared to 56 for IHE.
IHE vs IXJ: Which Popular Healthcare ETF Is the Better Buy for Investors?
08:16pm, Saturday, 18'th Jul 2026
iShares Global Healthcare ETF provides exposure to 110 international stocks, whereas iShares U.S. Pharmaceuticals ETF concentrates on 56 domestic companies iShares U.S. Pharmaceuticals ETF has higher
Which Pharmaceuticals ETF Is Better, the iShares IHE or State Street XPH?
08:35am, Thursday, 16'th Jul 2026
The iShares U.S. Pharmaceuticals ETF is larger by assets under management and offers a higher trailing dividend yield. The State Street SPDR S&P Pharmaceuticals ETF has delivered higher one-year retur
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?
07:21am, Wednesday, 15'th Jul 2026
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
10:56am, Tuesday, 14'th Jul 2026
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?
06:41am, Friday, 10'th Jul 2026
The iShares U.S. Pharmaceuticals ETF (IHE) offers a lower expense ratio and a significantly higher dividend yield than the iShares Biotechnology ETF (IBB). IBB offers broader diversification, with 248
IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?
11:16am, Sunday, 05'th Jul 2026
The iShares U.S. Pharmaceuticals ETF (IHE) charges a lower expense ratio and pays a higher dividend than the Invesco Pharmaceuticals ETF (PJP). IHE is heavily concentrated in its two largest holdings,
Big Pharma's Looming Patent Cliff Period And How It Is Trying To Address It
05:00pm, Monday, 29'th Jun 2026
Big pharma's patent cliff risk is somewhat overstated, as layered IP and litigation often extend exclusivity beyond headline expiries. Incremental innovation—new formulations, improved delivery, and
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors?
03:46pm, Wednesday, 17'th Jun 2026
iShares U.S. Pharmaceuticals ETF offers a significantly higher dividend yield and lower volatility than State Street SPDR S&P Biotech ETF. While State Street SPDR S&P Biotech ETF delivered stronger 1-
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
07:14am, Thursday, 11'th Jun 2026
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect
